Subscribe
e
Xconomy’s Digital Events →
▾
Xconomy National
Our
Regions
National
›
Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
View More in National ›
Europe
›
FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
View More in Europe ›
Boston
›
Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
View More in Boston ›
Boulder/Denver
›
BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
View More in Boulder/Denver ›
Detroit/Ann Arbor
›
BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
View More in Detroit/Ann Arbor ›
Indiana
›
BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
View More in Indiana ›
New York
›
“Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
View More in New York ›
Philadelphia
›
BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
View More in Philadelphia ›
Raleigh-Durham
›
BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
View More in Raleigh-Durham ›
San Diego
›
Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
View More in San Diego ›
San Francisco
›
BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
View More in San Francisco ›
Seattle
›
BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
View More in Seattle ›
Texas
›
BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
View More in Texas ›
Wisconsin
›
BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
View More in Wisconsin ›
Topic
Channels
Life Sciences
›
View More in Life Sciences ›
Healthtech
›
View More in Healthtech ›
Robotics and A.I.
›
View More in Robotics and A.I. ›
Startups
›
View More in Startups ›
Our
Events
All Xconomy Events ›
Xconomy
Insight
Topic Channels
Healthtech
Life Sciences
Robotics and A.I.
Startups
Life Sciences
Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
Roche Enlists Dyno to Bring AI to Next-Generation Liver, CNS Gene Therapies
Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
SQZ Biotech Lines Up an IPO on the NYSE to Fund Cell Therapy R&D
Life Sciences Home
Healthtech
Code for Cures: Life Sciences Thrives on San Francisco’s Software Heritage
Healthcare AI Tech is Here, Now We Must Learn to Manage the Data
AI Can Unlock Health Data’s Potential, But Access Is Still Difficult
Nuance & Microsoft Team Up on Conversational AI for Doctors’ Offices
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
Healthtech Home
Robotics and A.I.
Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
Data Quantity, Complexity Drives Use of AI in Drug Discovery and Testing
Akili Interactive’s Video Game for ADHD Gets the FDA All Clear
Biotech “Mapmaker” Immunai Launches With $20M to Chart the Immune System
Robotics and A.I. Home
Startups
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
Federation Bio Bags $50M to Engineer New Approach to Microbiome Drugs
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
Bio Roundup: Grail Acquisition, Libra’s Launch, Tau Trial Results & More
Combined Therapeutics Inc Wins $250,000 MilliporeSigma Advance Biotech Grant
Startups Home
Underwriters and Partners
Xconomy on Demand
We offer a number of ways to
subscribe for free!
Subscribe Now